PolyNovo (ASX:PNV) logged AU$0.0105 in earnings per share for fiscal 2026, compared with AU$0.0189 a year ago, a Wednesday filing showed.
For the 12 months ended June 30, total revenue was AU$150 million versus AU$129.2 million previously, the Australia-listed medical technology company added.